Skip to main content

Harmful Association Identified Between Traffic Pollution, Amyloid Plaques

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 22, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Feb. 22, 2024 -- Traffic-related fine particulate matter (PM2.5) affects the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) score, according to a study published online Feb. 21 in Neurology.

Grace M. Christensen, Ph.D., from the Emory University School of Medicine in Atlanta, and colleagues conducted a cross-sectional study using 224 brain tissue donors who died before 2020. Alzheimer disease (AD) pathology was assessed among donors using the Braak stage, CERAD score, and combined AD neuropathologic change (ABC) score. The association between traffic-related PM2.5 (based on measurements of one-, three-, and five-year average PM2.5 concentrations before death matched to home addresses) and AD hallmark pathology was examined.

Of the participants, 57 percent had at least one APOE ε4 copy. The researchers observed a significant association for traffic-related PM2.5 with the CERAD score for the one- and three-year exposure windows (odds ratios, 1.92 and 1.87, respectively). Nonsignificant associations were seen for PM2.5 with Braak stage and ABC score. Those without APOE ε4 markers had the strongest associations between PM2.5 and neuropathology markers (e.g., odds ratio, 2.31 for the CERAD score and one-year exposure window); however, the interaction between PM2.5 and APOE genotype was not significant.

"Our study found traffic-related PM2.5 exposure was associated with the CERAD score at autopsy, contributing to a growing body of evidence that PM2.5 affects β-amyloid deposition in the brain," the authors write. "More research is needed to establish causality for the association between PM2.5 and AD, including epidemiologic and mechanistic studies."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted February 2024

Read this next

Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care

TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...

Emergence of Psychosis in Alzheimer Disease Linked to Elevations in p-tau181

MONDAY, July 1, 2024 -- For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine...

Lower Cognitive Function in Adolescence Linked to Stroke Risk

FRIDAY, June 28, 2024 -- Lower cognitive function in adolescence is associated with increased risk of early-onset stroke, according to a study published online June 27 in the...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.